Glioblastoma Clinical Trials in Dallas, TX

Glioblastoma Clinical Trials in Dallas, TX

View the best 10 glioblastoma medical studies in Dallas, Texas. Access promising new therapies by applying to a Dallas-based Glioblastoma clinical trial.

Top rated glioblastoma clinical trials in Dallas, Texas

Here are the top 9 medical studies for glioblastoma in Dallas, Texas

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: April 23rd, 2024

Image of University of Southern California in Los Angeles, United States.

Perillyl alcohol

Monoterpene

Recruiting1 awardPhase 1 & 2
This trial is testing a new way to administer a drug, perillyl alcohol, to patients with brain tumors. The goal is to see if it is safe and effective. Up to 24 patients will be enrolled in the first phase of the trial, and 25 in the second phase. The drug will be administered four times a day for 28 days, and patients will be monitored for side effects and effectiveness.
Image of Dana Farber Cancer Institute in Boston, United States.

Sacituzumab Govitecan

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will test an experimental drug on patients with no other options.
Image of Children's Hospital of Alabama in Birmingham, United States.

Palbociclib

CDK4/6 Inhibitor

Recruiting1 awardPhase 2
This trial studies how well palbociclib works in treating pediatric patients with Rb positive solid tumors, non-Hodgkin lymphoma, or histiocytic disorders.
Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Vidant Health in Greenville, United States.

GammaTile radiation therapy implantation +3 More

Brachytherapy

Recruiting3 awardsPhase 4
This trial will assess the feasibility and tolerability of addingGammaTile radiation therapy as an upfront boost at the time of maximum safe resection, along with the backbone of the current standard of care approach, concomitant and adjuvant temozolomide +/- TTF, for patients with newly diagnosed GBM.
Image of Grandview Cancer Center in Birmingham, United States.

OptuneĀ®

Device

Recruiting1 award12 criteria
This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide +2 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.
Image of Littleton Adventist Hospital in Littleton, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Image of Children's Hospital of Alabama in Birmingham, United States.

Veliparib +2 More

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.

Popular filter options for glioblastoma dallas trials

Age 65+
Phase 3
< 50 mile distance
No Placebo

Clinical Trials With No Placebo

View 26 medical studies that do not have a placebo group.

Birmingham, Alabama

PARP Inhibitor

Veliparib + Radiation + Temozolomide for Brain Cancer

Recruiting1 awardPhase 2
Little Rock, Arkansas
This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.
Birmingham, Alabama

CDK4/6 Inhibitor

Palbociclib for Advanced Solid Cancers and Non-Hodgkin Lymphoma

Recruiting1 awardPhase 2
Dallas, Texas
This trial studies how well palbociclib works in treating pediatric patients with Rb positive solid tumors, non-Hodgkin lymphoma, or histiocytic disorders.
Birmingham, Alabama

PARP Inhibitor

Olaparib for Cancer

Recruiting1 awardPhase 2
Dallas, Texas
This trial is testing how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in DNA damage repair genes.
Birmingham, Alabama

Kinase Inhibitor

Larotrectinib for Advanced Cancer

Recruiting1 awardPhase 2
Dallas, Texas
This trial is testing larotrectinib, which may stop the growth of cancer cells, in patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have spread and come back or do not respond to treatment.
Anchorage, Alaska

Tyrosine Kinase Inhibitor

Ensartinib for Cancer

Recruiting1 awardPhase 2
Dallas, Texas
This trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or ROS1 genomic alterations.
Birmingham, Alabama

Tyrosine Kinase Inhibitor

Erdafitinib for Cancer

Recruiting1 awardPhase 2
Dallas, Texas
This trial uses erdafitinib to treat patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have spread and come back or don't respond to treatment with FGFR mutations.

View More Glioblastoma Dallas Trials

See another 11 medical studies focused on glioblastoma dallas.

Tipifarnib

Ivosidenib

Abemaciclib +1 More

MRI with Arterial Spin Labeling (ASL)

Radiation Therapy

Pembrolizumab +1 More

Exablate Model 4000

GammaTile radiation therapy implantation +3 More

Pemigatinib

BDTX-1535

Berubicin +1 More

View more glioblastoma clinical trials dallas

See more medical studies focusing on glioblastoma dallas

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top